Evidence map›Paper›PMID 28901188›Full record

ArticleCell transplantation2017

Engineered Microvasculature in PDMS Networks Using Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.

Amogh Sivarapatna, Mahboobe Ghaedi, Yang Xiao, Edward Han, Binod Aryal, Jing Zhou, Carlos Fernandez-Hernando, Yibing Qyang, Karen K Hirschi, Laura E Niklason

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Mechanical regulation of signal transduction in angiogenesis.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amogh Sivarapatna1 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Mahboobe Ghaedi2 Department of Anesthesiology, Yale University, New Haven, CT, USA.
Yang Xiao1 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Edward Han1 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Binod Aryal3 Section of Comparative Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA.
Jing Zhou1 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Carlos Fernandez-Hernando3 Section of Comparative Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA.
Yibing Qyang4 Department of Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
Karen K Hirschi4 Department of Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
Laura E Niklason1 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Yale University · US

Funding

Tissue Chips for Rare Disease: Adding Timothy Syndrome to the HeLIVaSkCa platformUH3EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2014 to 2016
$7.1M
Neurovascular RegenerationR01EB016629 · NIBIB · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER · 2014 to 2018
$4.8M
Multi-tissue platform for modeling systemic pathologiesUG3EB025765 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI VUNJAK-NOVAKOVIC, GORDANA · 2017 to 2019
$2.8M
Specification of Hemogenic Endothelial CellsR01HL128064 · NHLBI · YALE UNIVERSITY · PI DICKINSON, MARY E, HIRSCHI, KAREN KEMPER · 2015 to 2018
$2.6M
Hyaluronan Coatings for Engineered VesselsR01HL127386 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2016 to 2019
$2.5M
Human tissue-engineered blood vessels using induced pluripotent stem cellsR01HL116705 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2013 to 2017
$2.0M
NHLBI NIH HHS R01 HL116705NHLBI NIH HHS R01 HL127386NHLBI NIH HHS R01 HL128064NIBIB NIH HHS R01 EB016629NIBIB NIH HHS UG3 EB025765NIBIB NIH HHS UH3 EB017103
6 · The paper itself

Abstract

In this study, we used a polydimethylsiloxane (PDMS)-based platform for the generation of intact, perfusion-competent microvascular networks in vitro. COMSOL Multiphysics, a finite-element analysis and simulation software package, was used to obtain simulated velocity, pressure, and shear stress profiles. Transgene-free human induced pluripotent stem cells (hiPSCs) were differentiated into partially arterialized endothelial cells (hiPSC-ECs) in 5 d under completely chemically defined conditions, using the small molecule glycogen synthase kinase 3β inhibitor CHIR99021 and were thoroughly characterized for functionality and arterial-like marker expression. These cells, along with primary human umbilical vein endothelial cells (HUVECs), were seeded in the PDMS system to generate microvascular networks that were subjected to shear stress. Engineered microvessels had patent lumens and expressed VE-cadherin along their periphery. Shear stress caused by flowing medium increased the secretion of nitric oxide and caused endothelial cells s to align and to redistribute actin filaments parallel to the direction of the laminar flow. Shear stress also caused significant increases in gene expression for arterial markers Notch1 and EphrinB2 as well as antithrombotic markers Kruppel-like factor 2 (KLF-2)/4. These changes in response to shear stress in the microvascular platform were observed in hiPSC-EC microvessels but not in microvessels that were derived from HUVECs, which indicated that hiPSC-ECs may be more plastic in modulating their phenotype under flow than are HUVECs. Taken together, we demonstrate the feasibly of generating intact, engineered microvessels in vitro, which replicate some of the key biological features of native microvessels.

Indexed as

Cell Culture TechniquesCell DifferentiationDimethylpolysiloxanesEndothelial CellsHumansImmunohistochemistryInduced Pluripotent Stem CellsDimethylpolysiloxanesarterialendothelial cellshuman induced pluripotent stem cells (hiPSCs)microfluidicsmicrovesselsshear stress

Identifiers

PMID28901188
PMCPMC5680973
OpenAlexW2593453525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.